HOME     |     CONTACT
Phase I Trial of GRNOPC1

A new chapter in medical therapeutics — one that reaches beyond pills to a new level of healing:  the restoration of organ function achieved by the injection of healthy, functional replacement cells manufactured from human embryonic stem cells.

Video Illustration of GRNOPC1 in an
Animal Model of Spinal Cord Injury


1. Human Embryonic Stem Cells (hESCs)
2. Oligodendrocyte Progenitor Cells (GRNOPC1)
3. Preclinical Safety Studies
4. Clinical Program
5. Manufacturing
6. Intellectual Property

Video of GRNOPC1 Manufacturing

Geron Initiates Clinical Trial of Human Embryonic Stem Cell-Based Therapy